Dividend Aristocrat AbbVie (ABBV) reported fourth-quarter earnings on Friday that were above consensus and the company raised its guidance for 2020. The company beats sales and earings expectations with 5.3% operational revenue growth and 16.3% growth in adjusted earnings-per-share.
AbbVie AbbVie is also raising its 2020 EPS guidance of $7.66 to $7.76, representing growth of 46.0%. AbbVie expects to deliver standalone adjusted diluted EPS for the full-year 2020 of $9.61 to $9.71, representing growth of 8.1%.
AbbVie has a strong dividend growth record. Its dividend grew by 195% since separating from Abbott Laboratories in 2013. The last dividend increase was +10% in November 2019. Current dividend yield 4.95%.
Source: press release
